2022 Speakers

After graduating as a lawyer and with a Master Degree in management, Anne has worked for 23 years in various International Medical Societies as Human Resources and Communication Director.

Besides her expertise in recruiting high level profiles for the medical industry or institutions, with a particular focus on start-ups and medtech, she is a specialist of team appraisal and change management  and has in depth experience in individual assessment and people development, with a professional Coaching Certification.

Antoine, as digital expert in healthcare and life sciences works closely with business decision makers in the pharmaceutical industry headquartered in EMEA.

Most of the topics he addresses are to help them get maximum value from the data on the entirety of their value chain for ultimately better health for all.

Antoine was previously director Health Innovation and Solution, driving Health (Life Sciences, Research, Provider and Gov) French global ecosystem to enable better healthcare experiences and improve community health outcomes with the latest healthcare innovations from leaders in the cloud industry.

After Graduating with a Master of Computing science from a French engineering school and experiences in software development followed by solution selling, Antoine joined software and services leader 20 Years Ago. Started with various roles of account executive in different industries.

Education

2007 – PhD in Food Microbiology and Biomathematics – VetAgro Sup Marcy l’Etoile – France

2003 – Engineer in Agronomy and Food Industries – ENSAIA Nancy – France

Work Experience

Since 2022 – Vice President of SIDIV (French IVD industries association)

Since 2018 – Head of HealthCare Development – Roche Diagnostics France

2017 – Regional Managing Director and Chief Operating Officer – Eurofins Medical Biology – France

2014 – Industrial and Purchasing Director – Eurofins Medical Biology – France

2012 – Strategy and Product Development Director – Roullier – France

2007 – R&D/Innovation Manager – bioMérieux – France

Antonio Sanchez-Cordero is the Worldwide Vice President of Business Development (M&A) at Becton Dickinson, Peripheral Intervention. Antonio is a versatile global executive with more than 15 years of experience in the healthcare industry, leading mid-to-large size multinationals in the areas of business development, strategy and M&A.

Formerly, Antonio was the Senior Vice President, Corporate Strategy, Business Development and Licensing at PDI Inc, a global leader in the infection prevention industry, and Vice President, Corporate Development & Strategy at Werfen, a global diagnostics company. Mr Sanchez-Cordero has also experience as an investor, having spent a portion of his career with healthcare-focused private equity funds like Ampersand Capital and Accelmed, as an Operating Partner.

Overall, Antonio is experienced at leveraging inorganic growth to build sustainable businesses in healthcare while further developing the strategy, the capabilities and the innovation pipeline of the organization.

Mr. Sanchez-Cordero completed an MBA from ESADE Business School and Ross School of Business (University of Michigan), and has received a Bachelor’s degree in Law from Pompeu Fabra University (Barcelona, Spain). He regularly participates as a speaker and a panelist in global conferences in the fields of strategy, innovation and corporate development in healthcare.

Arezki Yaïche is since 2014 a financial journalist specialised in M&A and EU competition law. As a Senior France Correspondent and Paris Bureau Chief for the global M&A newswire Mergermarket (owned by ION Group), he writes on all types of transactions from competition issues, early stage fundraises, and private deals to takeovers of listed companies and IPOs.

Arezki was previously Senior Correspondent Antitrust for regulatory newswire MLex in Brussels between 2019 and 2021. Before that he worked four years as M&A reporter and Paris Bureau Chief for Mergermarket. Arezki also has a six-year experience as Communication consultant specialised in Finance and EU regulation. He worked for financial and public institutions including Dexia Asset Management in Brussels, Credit Agricole Assurances in France, the French embassy in Stockholm, the European Parliament, and the French Ministry for Agriculture

Arnaud Attyé is neuroradiologist in Grenoble University Hospital (France) and holds a PhD in Neurosciences. He founded GeodAIsics in 2021 to improve patient outcomes by revolutionizing treatment techniques based on Responsible Artificial Intelligence.

​Artur Olesch is a Berlin-based freelance journalist and correspondent for digital health-related topics. He is the founder of aboutDigitalHealth.com and editor-in-chief of ICT&Health International and OSOZ News. An author of 500+ articles and health-IT reports. Content writer, speaker, conference moderator, an influential voice on social media, digital health advocate. He mentors med-tech startups and guides healthcare organizations aiming to develop digital strategies.

As a correspondent, Artur describes the latest technological, scientific developments in medicine and their impact on the health and well-being sector today and in ​​​the future. Artur has been working with leading healthcare and health IT organizations like The Healthcare Information and Management Systems Society (HIMSS), World Health Organization (WHO,) Copenhagen Institute of Future Studies, EIT Health. He is also a member of the SCIANA Healthcare Leaders Network.

Baudouin is a Partner at Karista, early stage Venture Capital firm established in 2001, and investing across Europe.

Pioneering Digital Health investments in Europe as from 2006, Karista is one of the very few European VCs cumulating a Life Science and a Digital practice and having a specific Digital Health strategy. Since 2018 the team manages a dedicated Digital Health fund, in partnership with several Top Tier corporates across the healthcare value chain.

Joining Karista in 2014 Baudouin is focusing at Digital Health and Life Science investments. He is a Board Member or Observer of several Karista portfolio companies, including: Implicity (Digital Health, France), MoveUP (Digital Health, Belgium), Kranus Health (Digital Health, Germany), HTC Assistance (MedTech, France), Tricares (MedTech, Germany), Watchfrog (Service biotech, France).

Baudouin holds a MSc in Engineering from the University of Technology of Compiègne and graduated from ESSEC Business School.

Dr Faurie is an interventional cardiologist at Cardiovascular Institute of Grenoble and Medipole Lyon-Villeurbanne (FRANCE). He completed his medical training at the University of Grenoble and then a post-graduate fellowship in Quebec Lung and Heart Institute, Laval University, Canada. He got university post-graduate diploma in interventional cardiology, percutaneous treatment of heart valves disease. He has been founder and a scientific committee member for several nationals and internationals Meetings, Workshops and regulary provide educational live cases. Dr Faurie has published papers in peer-reviewed journals and regularly presents educational and scientific work at international meetings. He is also the founder of Electroducer, a breaktrough medtech company focusing on simplify and secure complex PCI and THV interventions. This technology is based on the Direct Wire Pacing technique that he developed and whose superiority has been proven by randomized studies.

Chris Robson is a CEO and Entrepreneur, working at the forefront of healthcare innovation, with 20 years’ experience of identifying and creating new products and businesses with digital technology. He built and floated digital agency, Syzygy, on the German Stock Exchange with a market cap of €240m and co-founded Ink Publishing, the world’s largest publisher of inflight media. He is now building Living With, a highly modular remote patient management platform, to help clinicians to assess, monitor, rehabilitate and support patients at home and in the community, across urology, urogynaecology,  colorectal, rheumatology, oncology, respiratory and long Covid. Living With owns the UK’s top paid medical app Squeezy, and works in 40 NHS Trusts. Chris is the author of “Confessions of an Entrepreneur”, published by Pearson.

Mr Christoph Jo. Müller
He is working in the assistive technology industry since more than 30 years and has a background in electrical engineering. 1990 Founder and CEO of INCAP GmbH, (AT manufacturer and service provider), 2006 Founder and CEO ATNAD, Inc., Texas, USA (AT Distribution), Founder of a few internet platforms for AT. After a merger of INCAP and CSS MicroSystems GmbH he is member of the board as Executive Vice President Sales and Business Development. He is also working as a consultant for start ups and health insurance companies.
He is Co-President of DATEurope, the European Digital Assistive Technology Industry Association. Since 1997 he is President of the Board of Directors of BEH (Assistive Technology Industry Association, Germany) and was member of the Board of Directors of ATIA Assistive Technology Industry Association 2011 to 2014. He was speaker and moderator at several conferences (e. g. M-Enabling Europe, ATIA, Accessible Europe, ATAAC, MAIK, ZeroProject).

A former academic turned life-science entrepreneur. I have recently taken over responsibility for establishing a global AI competence center

– focused on supporting AI-driven startups – funded by the German federal government.

Since 2017, I have split my time between academia and the health-tech industry. A two-times technical founder, I have built and sold products across pharma, med-tech and the clinical sectors.

My academic publications include a Product Development Framework for AI in Healthcare, and multiple Regulatory Best-Practices (GMLP) guides.

I mentor AI driven health-tech spin-outs across Europe and the USA. I write about AI in Healthcare on my blog http://digitizingbiology.com.

I am a mathematician and computer scientist with a PhD in Computational Neuroscience from the École Normale Supérieure (Paris).

Esther Rodijk is a Technical Physician by training, with special interest in the valorization of innovative medical technologies. After completing a PhD in medical robotics, she worked at the Technical Medical Centre at the University of Twente in coordinating collaboration between researchers and companies. She is currently innovation scout at UT’s Knowledge Transfer Office and running a Dutch national program of Thematic Technology Transfer in MedTech. This program is a collaboration of KTO’s from technical and medical universities to create more and better spinouts in the medical technologies. Read more about it on the site: https://tech-transfer.nl/en/

Eyal Lifschitz is an entrepreneur and investor with years of experience in establishing and managing life science companies and their business development efforts.

Lifschitz serves as the Co-founder and Managing General Partner of Peregrine Ventures, a global life science venture capital fund dedicated to improving patients’ quality of life by investing in and supporting life changing healthcare opportunities. In this role, he oversees all daily operations and mentors entrepreneurs on their journeys to bring innovative medical technologies to market.

On behalf of Peregrine, Lifschitz serves on the boards of Memic Innovative Surgery, Ribon Therapeutics, CardioValve, Nectin Therapeutics, Restore Medical, Kahr, Cordio Medical, Raziel Therapeutics and others.

Previously, Lifschitz was involved as a founder and a manager in PharmaSys (acquired by Elan Corp. NYSE: ELN), ECR (acquired by AVX Corp. NYSE: AVX), Visioncare Ophthalmic Technologies, BioControl, and as a director of Given Imaging (NASDAQ: GIVN).

Lifschitz serves as Chairman in the Israeli Early-Stage Investors Association (IEI) & Technology Incubator Forum (ITIF) which promotes Israeli high-tech ventures both domestically and abroad. Lifschitz is also a Founder and Chairman of GamVeGam, a non-for-profit cooperation between the Israeli Ministry of Education and the Israeli high-tech industry which aims to encourage high-tech professionals to become teachers in public schools.

He holds an LLB from the Academic Center for Law and Science.

Fabian Scheugenpflug is a trained medical physicist and leads the venture’s activities for Plug and Play Health EMEA. He has been the first team member of Plug and Play’s joint Venture with Roche Diagnostics – Startup Creasphere, a digital health innovation framework.

As part of his role, Fabian works with a multitude of Fortune 500 companies on specific projects ranging from enhanced POC capabilities to improving access to healthcare in the global south. Since the inception of Startup Creasphere Fabian has been leading more than 90 pilots. Additionally, he played a vital role in the expansion of Startup Creasphere to Asia and America. Besides his corporate engagement, Fabian has led investments into 12 early-stage digital health startups which truly transform the perception of future healthcare. Some of his prominent portfolio firms include TestCard, Hyfe and Dyad.

François Hédé a créé et mené au succès deux startups technologiques en tant que président (Cycléo et Idosens). Habitué au management d’entreprises, iI a auparavant mené une carrière internationale d’une quinzaine d’année au sein de grands groupes industriels leaders en électronique. Il assure la présidence et le pilotage de l’activité de Linksium depuis septembre 2021.

Frank has been active a VC investor for 25 years across the full ecosystem of health tech and life sciences.

His key reason for joining imec.xpand was the focus on ground breaking nanotechnologies through a strategic line-up with the imec research institute. The disruptive nature of the achievements in this field is now allowing breakthroughs in product and platform development with medical impact which was non-existing 10 years ago.

Making impact in the medical field through emerging tech is his ambition. An unique approach to allow for earlier diagnosis and more efficient disease treatment paradigms are prerequisites for a sustainable health care system.

Frank is an industrial engineer in chemistry/biochemistry and obtained a Master Degree as well as a PhD in Medical Sciences at the University of Leuven, Belgium.

Après plus de 10 ans d’expérience dans la e-santé en tant que business developper, country manager et directeur général en start-up et grand groupe, Géry a rejoint Lifen pour accélérer l’intégration des éditeurs de solutions e- santé à l’écosystème Français.

Convaincu que la e-santé est une des solutions aux grands enjeux de santé de demain, la plus grand motivation de Géry est de la rendre plus accessible pour les patients, professionnels de santé et éditeurs.

Hugh is an experienced clinician and health technology advisor, with a focus on leveraging big data and artificial intelligence. He is a board certified consultant radiologist and academic, trained in the NHS and Europe’s leading cancer research center, the Institute of Cancer Research, where he was twice awarded ICR Science Writer of the Year. He is currently Managing Director at digital health consultancy Hardian Health.

He has previously held lead roles at two flagship UK startups, leading to successfully gaining the world-first CE marking for an AI-supported triage service, and the first UK CE mark for a deep-learning medical device.

He was a co-opted member of the Royal College of Radiologists informatics committee and sat on their AI policy reference group. He also acted as co-chair to the Topol health technology review for Health Education England commissioned by the Secretary of State for Health and Social Care.

He now serves as board advisor to many AI start-up companies across the globe and retains an academic interest as a board member of the global open source scientific journal Nature: Digital Medicine, and holds an honorary research fellowship at the Institute of Cognitive Neurosciences at UCL.

Ivo Aarninkhof is founder of Holland Innovative in Enschede The Netherlands (www.holland-innovative.nl) and CEO of Sigmascreening B.V. (www.sigmascreening.com) and co-founder of several Medtech companies. Aarninkhof has 20+ years executive management experience as board executive and board member, started and managed several high-tech / med-tech companies and held senior management positions for Philips in Europe as well as in China. Aarninkhof is board member of the Dutch employers’ organisation in the technology industry FME (https://www.fme.nl/) and member of the Supervisory Board of ‘’Academy Het Dorp’’ (https://www.academyhetdorp.nl/) for long term care patients. Aarninkhof holds a MSc. degree from the University of Twente in Acoustics in The Netherlands and an executive MBA in Finance from Vlerick Belgium/St Gallen Switzerland/Nyenrode The Netherlands. Aarninkhof has published a book in 2021 (NL) and 2022 (EN) with the title ’Entrepreneurial Innovation’.

James is Venture Partner at MedTech SuperConnector. He brings venture capital investment, corporate, and board experience from supporting venture-backed companies in the UK, Europe, and the US.

James was previously Investment Principal at Oxford Science Enterprises, where he focused on life sciences investing and served on the boards of university spinout portfolio companies. Before this, he was Head of Corporate Advisory at Mercia Asset Management and Investment Director at Fosun Pharma.

This built on his experience as Investment Manager at NBGI Ventures, where he focused on medical technology investing and served in board roles of portfolio companies in the UK, Europe, and the US.

James started his career at Cambridge Consultants and holds an MPhil in Computational Biology from the University of Cambridge, funded by the UK’s Engineering and Physical Sciences Research Council.

At GE Healthcare, we know that ecosystems are the key to success in the modern business world. Be it close collaboration with global, leading technology companies, broader engagement with organizations across mutual interest areas or mass market nurturing of the developer community, it’s the support in the community and the vibrancy of the outside activity around our products that really make them successful –as well as making our customers successful.
As Senior Director of the Digital Ecosystem, Jan’s role is to drive GE Healthcare Digital Europe’s Ecosystem Strategy and together with his team develop cooperation with partner companies, indirect channels, start-up centers and networks. Jan is the head of GE Healthcare’s EdisonTM Accelerator.
With over 15 years of experience in healthcare informatics, the medical imaging domain and management, Jan is a seasoned leader with vast experience in leading strategic initiatives and influencing strategic decisions that ultimately drive revenue and contribute to enterprise value.
Prior to joining GE Healthcare, Jan has held consultancy roles in Digital Health start-ups and Radiology IT companies. Prior to his Digital Ecosystem responsibility at GE Healthcare, he has been responsible for leading clinical consultancy at GE Healthcare Digital in Europe, Middle East & Africa where he and his team ensured and optimized the quality of clinical solution architecture, clinical workflow consultancy, change management and user adoption.
He brings a real passion for the digital transformation of healthcare, understanding healthcare provider needs, improving healthcare workflows and user experience.
Jan lives outside of Leipzig, Germany, with his wife and their two daughters and founded www.gr4ai.academy, a non-profit to create awareness and educate children around Artificial Intelligence.

Jennifer Goodall specializes in dynamic leadership and strategic vision coupled with strong financial expertise to drive the successful growth of hi-tech businesses. She is currently CEO of MindAffect, a ground breaking BCI/AI HealthTech Scale-up which was spun out of the University of Radboud and based in the Netherlands. Through her leadership, MindAffect has expanded the applications of its proprietary BCI Communication technology to develop new methods to screen, monitor and ultimately diagnose the neural pathways of all patients – not just those who can respond – (imagine how valuable this can be for children, the elderly and cognitively challenged patients!)  This expansion has resulted in a robust financial position with paid pilots from global corporates, large national grant awards and strong equity investor support. Financial stability, strategic alignment between Technological Research and Product Development, strong risk/reward management and scrupulous communication underline her success. A graduate of Harvard with a BA in Computer Science and the Wharton School with an MBA in Finance, Jennifer’s original career was the typical NY Wall Street and then Amsterdam international investment banker. However, after many successful years in leadership positions “selling money” to established corporates, she decided to leave banking in order to work with exciting, young companies to have a positive impact on the quality of care for patients. The mother of two grown boys, wife of a Dutch lawyer and sporadic (but devoted) Ashtangi, Jennifer lives and works by the sea in the Netherlands (when she hasn’t run off to the sunny hills of Mallorca on a yoga retreat.)

Jennifer has served in large-scale public health systems in Canada implementing Electronic Medical Records as well as developing and implementing both operational and legislative health policy and strategy. She has been with Roche for the last 6 years and currently serves as the Global Data Policy Strategy Lead supporting countries around the world. She has a Masters of Business Administration, a Masters of Public Health with a specialization in Policy, a certificate in Data: Law, Policy & Regulation from the London School of Economics and is a Certified Health Executive with the Canadian College of Health Leaders. She serves on the EFPIA Digital Health Working Group, Digital Europe Digital Health Working Group and the BIO Digital Trade Task Force focusing on progressing data and digital policy globally.

Jhonatan Bringas Dimitriades, MD is a Medical Doctor and executive who works with technologists, developers, medical professionals and patients to deliver digital and technical solutions to enhance the diagnosis, treatment, recovery and quality of life of patients around the globe.

Jhonatan believes in the democratization and digitalization of medicine. Dr. Bringas has worked in the implementation of medical technologies in some of the top medical centers worldwide. His work related to medical implementation of technologies, digital health, and innovation has been featured in written and spoken media. Jhonatan is one of the co-Founders of Lapsi Health, Digital Health startup that is developing Digital Biomarkers for multiple usages in Medicine, he is also the CEO of JBD HealthCare, a global consultancy firm on medical technology development, implementation and digital transformation of medical organizations.

Jhonatan is a certified Occupational Physician, with postgraduate education in Public Health, Business Strategy and Digital Health. Jhonatan holds a Medical Degree, re-certified in 3 continents and has held the positions of Medical Director and Chief Medical Officer at a number of companies. He currently has appointments as faculty in Digital Health at several universities.

Joop Tanis is Director of MedTech Consulting at Health Tech Enterprise (HTE), delivering technology advisory services and innovation management to industry and the NHS.

HTE’s MedTech Consulting team provide tailored advice and support for medtech companies, healthcare organisations, universities and government programmes. They understand markets, provide insights, investigate health economics, facilitate connections, manage IP and advise on funding and regulation and conduct impact evaluations.

Trained as a Chartered Physiotherapist, Joop’s clinical and managerial career in the NHS have given him a deep understanding of the clinical, organisational and financial levers that drive innovation in this complex healthcare environment. His experience connects clinical practice, organisational demands, medical technology and industry, to enable successful commercialisation of innovative solutions.

Previous roles include Head of Innovation at Health Enterprise East and Director of The Young Foundation’s Health Launchpad innovation fund. Joop has founded several businesses in healthcare and outside. He is a business mentor at the Wayra/Telefónica digital incubator.

Nina Capital is a venture capital firm investing in needs-driven founders building health tech companies (operating at the intersection of advanced technologies and healthcare) with international ambitions. As a venture partner, I help the firm identify the right companies and then help the founders of those portfolio companies with advice and connections.

Previously, Jorge was Director of Innovation (portfolio of over 125 large-scale projects) and member of the Executive Management Board of EIT Health, an independent body of the European Union, mandated to accelerate innovation and entrepreneurship in healthcare and life sciences in Europe. He has extensive knowledge of healthcare systems in Europe, both from the providers’ side as well as corporates, startups and investors.

Jorge was Director of E-Health within the Innovation Department at Hospital Sant Joan de Déu Barcelona (2010-2018) and Director of Moebio, a Stanford Biodesign program where interdisciplinary teams experience a full cycle of innovation, from need identification through invention to early-stage implementation.

Jorge has more than 20 years of experience, with the last fifteen years fully dedicated to innovation, technology and entrepreneurship at the intersection of business, government, and academia.

He regularly acts as advisor and mentor to healthcare and life sciences startups and entrepreneurial acceleration programs across Europe.

PERSONAL LINKS:

• LinkedIn: http://www.linkedin.com/in/jorgejuanfernandez
• Twitter: @jorgejuan

PROFESSIONAL LINKS:

• Nina Capital: https://www.nina.capital/
• EIT Health: https://eithealth.eu/
• Hospital Sant Joan de Déu – Barcelona: https://www.sjdhospitalbarcelona.org/
• Moebio / Biocat: https://www.moebio.org/

Over the cause of the years, Kevin has proven himself as Market Access & Reimbursement leader, leading currently the HEMAR team for Connected Care globally in Philips. In his leadership role, Kevin is directly involved in the Global Strategy, platformization & digitization and launch readiness for the key solutions enabling delivery of care across settings to improve the quadruple aim and ensuring that the right patients get timely and maintained access to health technology solutions and applications at the right time at the right price. Prior to joining Philips, Kevin spent over 10 years in the pharmaceutical industry. Next to his pharmacy background, Kevin holds a MBA and Health Economic degree.

Former Managing Director Europe Qualcomm Life, 25 years of experience in the development, launch and operation of end-to-end services for enterprises among which 8 years in digital health, RPM and connected therapies for the pharma, MedTech and large integrators, service providers and HCPs in Europe and in the US.

Lionel Tussau is leading the global healthcare strategy at the product content solution provider atrify, a company enabling UDI registrations into Regulatory databases (such as EUDAMED or GUDID) and GDSN connections between manufacturers, wholesalers, GPOs, and hospitals. He represents atrify in MedTech Europe (chairman of the EUDAMED IT Expert group), is an observer in the EUDAMED MDCG working group, and member of the GS1 Global Healthcare Leadership Team.

Marie Laulhé is start-up manager for 3 years in the Bio-incubator team at Eurasanté. After bioengineering studies at the University of Technology in Compiègne, she worked for 6 years at MacoPharma as project manager for the development of extracorporeal photopheresis medical devices. In 2018,  she had an entrepreneurial experience in a digital start-up.

With her medtech expertise, she promotes today the development of medtech innovative companies from their early stage to their seed fundraising. She accompanies the project managers to secure the intellectual property, finalize their POC, search for partners, prepare the business strategy and market access, activate fundings, and if needed she helps them to find the right CEO or cofounders to manage the project.

Maxime Cervino is the Sales Manager Southern Europe for Chronolife. Chronolife is a digital health service operator delivering continuous and multi-parametric monitoring of patients in real-life conditions through healthcare certified smart textile. The company has already signed deals in different fields such as HCPs, Medtechs, Pharmas or integrators. In his current role, Maxime designs, builds and promotes long-lasting relationships with different kinds of collaboration models both with other start-ups and corporate.

Dr. Neel Patel is the co-founder and CEO of ZiO Health, a biotech startup bringing lab testing technology to the point of care to improve patient outcomes. It was while practicing as a doctor, Neel recognised the benefits an increase in the efficiency and turnaround time of diagnostics could bring both patients and medical professionals. Whilst completing his MBA at the University of Oxford, Neel set out to take this idea forward. He has raised five rounds of investment to bring ZiO Health’s AI-driven therapeutic drug monitoring device to market.

Former startup fundraising advisor and current Investment Manager.

Nina is responsible for supporting NLC ventures in their funding strategy and in building co-investment consortiums with other investors to invest in (predominantly) Seed and Series A financing rounds.

Philippe Cinquin, PhD in Applied Mathematics and MD, is Professor of Digital Public Health at Univ. Grenoble Alps (UGA) and Grenoble University Hospital (CHUGA). He is the former head of TIMC (UGA & CNRS), and belongs to Centre for Clinical Investigation (INSERM & CHUGA). He pioneered Computer-Assisted Medical Interventions, and contributed to the creation of several startup companies. He recently turned to intra-body energy scavenging in order to power implanted medical devices, and on the design of smart medical devices capable to modulate and to sample intestinal microbiota or to monitor heart function. He co-authored 145 papers and 43 patents. He was the recipient of the Muller Award for excellence in computer-assisted orthopedic surgery, of the CNRS Silver and Innovation Awards, of the Ambroise Paré Award (French Academy of Surgery). He was finalist for the European Inventor Award for a Glucose BioFuel Cell capable to power implanted medical devices. He holds “Deep Care” (a research chair of Grenoble Multidisciplinary Institute of Artificial Intelligence).

Przemek is an experienced executive advisor with over 100 completed strategy and commercial development projects. His work spans areas such as asset and portfolio strategy, new market entry, commercial due diligence and licensing, as well as regulatory approval, and market access strategy. Przemek has worked with many of the Top 20 pharmaceutical and medical devices companies, including on blockbuster and cutting-edge novel therapies.

Prior to founding milepoint, Przemek co-led the London office of Kx Advisors, a premier global healthcare strategy consultancy, and worked as a specialist consultant at McKinsey & Company, focusing on international mergers and acquisitions and regulatory strategy.

Przemek holds an MSc in Management of Innovation from the Rotterdam School of Management, Erasmus University, as well as a Bachelor of Business Administration, and a Bachelor of Laws from the University of Granada. He also completed post-graduate training in Private Equity and Venture Capital at IE Business School, Madrid.

Quentin Le Masne holds a Master’s Degree in Engineering from Ecole Centrale de Paris and a PhD in Physics from Paris University. He worked in various positions in the field of digital health & medical devices, leading engineering & development teams with diverse expertise like electronic, software development, mechanics, human factors, physics and manufacturing to bring new products in the doctor’s and patient’s hands.

Quentin is now in charge of the Solution Delivery team in the Global Digital Health unit at Merck. This team focuses on the development of novel digital health solutions across a variety of therapeutic areas.

Dr. Sascha Berger is a Partner at TVM Capital, based in Munich, Germany. TVM Capital is one the pioneer transatlantic Life Science Venture Capital funds with teams based in Europe and North America. Sascha joined TVM Capital in 2016, helped to raise the current $480M fund and works closely with entrepreneurs and founders to advance promising pharmaceutical assets, medtech, diagnostic and digital health technologies to the next value inflection points. Sascha is a passionate VC, a Boston Consulting Group alumnus, and has an academic background in chemistry and finance.

Sheena Pirbhai is the CEO and Founder of Stress Point Health and is passionate about mental health. Stress Point Health is the culmination of her personal journey to recover from PTSD following a major traumatic event, giving her a uniquely personal insight into the barriers to receiving treatment for mental health issues.

Stress Point Health is digital platform building the next generation of mental health tech with a focus on long term brain health. The company is doing this by bringing digitised Neurofeedback to the market for the first time and is refocusing the way mental health conditions are treated. Stress Point Health is unique in it’s focus on the emotional regulation centre of the brain, often overlooked in the treatment of a variety of mental health conditions. Their first product is SPHERE – an app using digitised Neurofeedback to deal with stress, anxiety and PTSD.

Sheena comes from a background in finance – fundraising and structuring M&A deals in the TMT sector.

Sheena is on a mission is to help and support people from all walks of life, delivering true positive impact on their lives. She serves on the board of Emerald Health, a company rebuilding the healthcare infrastructure for the Island of Montserrat and was named as one of the Top 100 Asian Stars in UK Tech 2022.

Suzanne Elvidge is a freelance medical writer based in the UK. She writes about medtech, pharmaceuticals and healthcare for print and online publications and clients worldwide.

Sylvain Poitras is a health-sector attorney-at-law supporting commercial operations and public sector clients worldwide, with a focus on cross-border matters. He is trained in law, public health and pharmacology. He is based in Geneva, Switzerland.

Sylvain is a Partner and Life Science Practice Head with Appleton Luff International Lawyers (AL), a specialty law firm focusing on issues of international trade, intellectual property, life sciences, arbitration, investment and public international law. The attorneys of AL are based in six countries on four continents and have a combined track-record of representing clients in matters in over 100 countries worldwide. AL is an agile, US-minded, geosavvy and human-size global boutique law firm.

A dual Canadian-Swiss national, Sylvain is registered as an attorney-at-law in the US (NY Bar) and Canada (Quebec Bar) and holds a Master of Public Health (MPH) in international health-sector management from Harvard University. In 2021, he was certified by the Harvard Medical School upon successfully completing a condensed training in pharmacology (pharmacokinetics, pharmacodynamic, toxicity, drug development).

Sylvain teams up with health-sector clients worldwide as their legal advisor, sparring partner, negotiation lead and, in several instances, fractional (part-time) General Counsel. He combines legal skills and health-sector insight with a COO state of mind to support smart and prompt business plan execution navigating health-sector contractual practices, health product regulation and antibribery compliance across borders. Clients include mature firms, start-ups, investors, non-profits, ethics committees, regulators and governments.

Over 30+ years in international life science, Sylvain led legal, business negotiation and compliance functions for business lines generating hundreds of millions USD/EUR in annual sales and closed on deals in tens of countries worldwide working with Big Medtech, Big Pharma and others, interfacing Europe-US and other cross-border health matters. Sylvain sat for several years on the Legal Affairs Group of Medtech Europe, the European medtech trade association (Brussels) and is an active member of Swiss Medtech, the Swiss medical device industry association (Bern).

Sylvain developed various new university courses on European healthtech law (regulatory qualification/pathway, CE-marking, contracting practices, anti-bribery compliance, innovation, research, IP, post-marketing duties, practical cases) which he has taught annually at two Swiss universities (EPFL & UNINE) since 2010.

Since its creation in 2016 he has been a mentor and judge with leading start-up accelerator MassChallenge Switzerland and was invited to join the MassChallenge Israel roster of mentors starting in 2020.

Thomas Hummel is heading Global Digital Transformation for Fresenius Kabi, a German healthcare group that engages in MedTech, Generics, Biosimilars and Medical Nutrition. In his current role at Fresenius Kabi he drives the transformation through Digital Lighthouse projects in the areas of Product Development and Innovation, Customer Engagement and Manufacturing and Supply Chain. Thomas has more than 25 years of broad digital experience in the healthcare environment and has worked in different roles for Siemens Healthineers, Merck KGaA, and Accenture in locations in France, Switzerland and Germany.

Tjaša Zajc is an internationally recognized digital health moderator and speaker focused on global healthcare digitalization. Brainlab put her on the list of 9 Digital Health Experts to Follow on LinkedIn in 2021, Health Tech listed her among 30 Healthcare IT Influencers Worth a Follow in 2021. She is the founder and host of Faces of digital health podcast, which is consistently ranked among the top digital health industry podcasts, she works as a business developer at the healthcare IT company Better, and is a patient advocate.

Tobias Silberzahn is a trained biochemist and immunologist and works as a Partner in McKinsey’s Berlin office where he is a member of the Healthcare and Innovation Practice. The focus areas of his work are healthcare innovation, health tech business-building and digital transformation.

Tobias leads the global Health Tech Network, a community of >1300 health tech companies, where he hosts the quarterly Health Tech CEO Roundtable. As part of his work, Tobias also hosts the MedTech R&D Industry Roundtable and publishes the “eHealth Monitor Germany”, an annual book about the digitization of the German health system.
Within McKinsey, Tobias leads the Health & Wellbeing program for employees, focused on sleep, nutrition, stress management and fitness, that was recently awarded the Brandon Hall HCM Excellence Award in Gold.

Vijay Sikka is the Founder, Chairman and Chief Executive Officer of Sikka Software Corporation. Under his leadership, Sikka Software has grown from a start-up to have over 35,000 practice installations and 125m patients on its platform for healthcare on the demand side and over 50 companies which have built applications on the supply side. Prior to Sikka Software, Vijay has worked in Artificial Intelligence and decision systems for more than 25 years with large scale projects at Intel Corporation, National Institutes of Health, Glaxo Smith Kline, Roche and UCSF affiliates. In 1996, Vijay founded IBrain Software, Inc. that used to compete with Informatica, Hyperion and Cognos and served as its CEO until its acquisition in 1998 by Entigen Corporation, a healthcare information company that later became part of Roche. After that Vijay co-founded Bodha.com that was acquired by Peregrine Systems/Remedy that later became part of BMC Software. Vijay holds an M.S. degree in EE and AI from Syracuse University, New York, pursued doctoral studies in neurosciences at Stanford University (incomplete Ph.D), and has been a Registered Continuing Education Provider in California. He is a frequent speaker at  AI, healthtech, technology and quality meetings. Vijay’s book on Maximizing ROI on Software Development was published by Taylor and Francis International and earns him a proud royalty check every few months.

Vijay was invited keynote speaker at the Digital Health World Conferences in 2019 and 2020, AI Global Forum 2020, 2021 and Biohacking Congress in London in 2020. He has published and presented in many artificial intelligence and neural network meetings and conferences including International Joint Conference on Neural Networks, SPIE, IEEE, AAAI and CHMT and the precursor of NeurIPS.

Biographie :

• • Work experience :
    • Since 2022 :       Board member – SIDIV (French IVD industries association)
    • Since 2021 :       Vice President EMEA Strategy, Business Development & Special Projects – Innova Medical Group Inc.
    • Since 2021 :       Operating Partner – TechLife Capital (Growth Private Equity)
    • 2019 :                  Chief Executive Officer – Assystem Care
    • 2015 :                  Senior Partner – Alcimed
    • 2011 :                  Partner – Alcimed
    • 2005 :                  Director – Alcimed
    • 2003 :                  Manager – Alcimed
    • 2001 :                  Consultant – Alcimed

Education :

• • 2001 :                  Double Engineering Degree in Design & Innovation of Bio-products – UTC (France) / Cranfield University (UK)

Vincent Poher is the cofounder and CEO of an In-Vitro Diagnostics company, AVALUN, which has spun out from CEA LETI in Grenoble. AVALUN has developed a portable and connected minilab, named LabPad, that allows for multiple biological tests to be carried out on a single reader just by changing the consumable microcuvette. Vincent has led the development of AVALUN from the proof of concept to the robotic production line and to the reimbursement in France. AVALUN joined the BIOSYNEX Group in 2021.

Vincent hold a PhD in optical microsystems from Physics Department of Imperial College London.

Xavier Bertrand is currently Vice President EMEA Healthcare Services & Alliances for Boston Scientific, a global leader in medical devices. He leads Hospital Solutions efforts, Capital Equipment programs, Digital Health and Business Development activities in EMEA. Prior to this role, Xavier was Global VP&GM Symetis, a Swiss TAVI leader acquired by Boston Scientific, leading all activities from R&D, Manufacturing to Commercial execution. He was previously Vice President, Europe Interventional Cardiology & Structural Heart. Prior to Boston, he managed the European structural heart business at Medtronic, and also served in smaller size companies like ATS Medical as General Manager EMEA or Biosensors International as VP Global Marketing. He started his career as SAP and change management consultant at Price Waterhouse Coopers, a global consulting firm.